Faruqi & Faruqi, LLP Launches An Investigation Against ACADIA Pharmaceuticals Inc. (ACAD) For Potential Breaches Of Fiduciary Duties By Its Board Of Directors Business Wire NEW YORK -- May 10, 2013 Juan E. Monteverde, a partner at Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, is investigating the Board of Directors of ACADIA Pharmaceuticals Inc. (“ACADIA” or the “Company”) (NasdaqGM: ACAD) for potential breaches of fiduciary duties in connection with their conduct in seeking shareholders’ approval for an amendment to the Company’s 2010 Equity Incentive Plan. Specifically, in the Proxy Statement filed by the Company with the Securities and Exchange Commission on April 25, 2013, the Board of Directors recommends that ACADIA’s shareholders vote to approve an amendment to the Company’s 2010 Equity Incentive Plan to increase the aggregate number of shares of common stock authorized for issuance under the plan by 7,500,000 shares. The issuance of the additional shares could have a substantial dilutive effect on the shares of ACADIA common stock. Request more information now by clicking here: www.faruqilaw.com/ACAD. There is no cost or obligation to you. Faruqi & Faruqi, LLP is a national law firm which represents investors and individuals in class action litigation. The firm is focused on providing exemplary legal services in complex litigation in the areas of securities, shareholder, antitrust and consumer litigation, throughout all phases of litigation. The firm has an experienced trial team which has achieved significant victories on behalf of the firm’s clients. If you own common stock in ACADIA and wish to obtain additional information and protect your investments free of charge, please visit us at www.faruqilaw.com/ACAD or contact Juan E. Monteverde, Esq. either via e-mail at email@example.com or by telephone at (877) 247-4292 or (212) 983-9330. Attorney Advertising. (C) 2013 Faruqi & Faruqi, LLP. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We are happy to discuss your particular case. Contact: Faruqi & Faruqi, LLP 369 Lexington Avenue, 10th Floor New York, NY 10017 Attn: Juan E. Monteverde, Esq. firstname.lastname@example.org Toll Free: 877-247-4292 Phone: 212-983-9330
Faruqi & Faruqi, LLP Launches An Investigation Against ACADIA Pharmaceuticals Inc. (ACAD) For Potential Breaches Of Fiduciary
Press spacebar to pause and continue. Press esc to stop.